Scott brings nearly three decades of commercial leadership experience across biopharma, with deep expertise in market access, pricing, trade, distribution, patient services, and commercial strategy. Throughout his career, he has led organizations through periods of transformation, built high-performing teams, and developed strategies that strengthen market position, improve execution, and drive sustainable growth.

Most recently, Scott served as Head of U.S. and Global Market Access, Pricing & Trade at Verona Pharma, where he led payer, access, pricing, and distribution strategy in support of the launch of Ohtuvayre. He has also served as Chief Executive Officer of both Luzsana Bio and Mirror Bio, where he helped advance clinical programs, raise capital, and guide organizations through critical stages of growth. In addition, he has held advisory and board roles, helping emerging organizations refine strategy, strengthen leadership teams, and prepare for their next stage of development.

Earlier in his career, Scott held senior commercial leadership roles at Merck KGaA, including U.S. Chief Commercial Officer and Global SVP of Market Access & Pricing, where he contributed to multiple successful launches and supported the growth of key brands. He also held leadership positions at UCB Pharma, Boehringer Ingelheim, and Johnson & Johnson. Across these roles, Scott has built a reputation for strategic clarity, disciplined execution, and the ability to align teams around a shared vision and measurable outcomes.